Catalyst Wire Dossier Catalyst Wire Dossier

Temozolomide

Temozolomide · Accord Healthcare Inc.
Drug timelines are a Plus or Pro feature.

437 regulatory and trial events tracked for Temozolomide, covering 2006-09-08 to 2026-08-24. Get the full timeline:

Most recent: Clinical Trial Results: A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer [Phase 1, Phase 2]

See pricing